Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

3.2K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recent advances in hepatic arterial infusion chemotherapy for conversion therapy of hepatocellular carcinoma].

Zhonghua yi xue za zhi·2026
Same author

[Application of multidisciplinary team diagnosis and treatment model in the management of patients with combined burns and heat stroke].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025
Same author

Enormous Myoma Pedunculated Through the Cervix: A Surgical Challenge.

Case reports in obstetrics and gynecology·2025
Same author

[Analysis of the misdiagnosis causes and treatment strategies for burns combined with alcohol withdrawal syndrome].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025
Same author

Design and Evaluation of RNA Aptamer-Mediated Delivery of C/EBP<i>β</i> siRNA for Oncological Therapy.

Journal of nucleic acids·2025
Same author

Histological results of para-aortic lymph node dissection in patients with negative PET-CT for locally advanced cervical cancer in Reunion Island.

Journal of gynecology obstetrics and human reproduction·2025

Related Experiment Video

Updated: Mar 2, 2026

Visualization and Quantification of TGF&#946;/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

3.9K

Thrombospondin-4 mediates TGF-β-induced angiogenesis.

S Muppala1, R Xiao1, I Krukovets1

  • 1Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.

Oncogene
|May 9, 2017
PubMed
Summary

Transforming growth factor-beta 1 (TGF-β1) promotes angiogenesis via thrombospondin-4 (TSP-4) in endothelial cells. TSP-4 mediates TGF-β1-induced tumor growth and angiogenesis, offering therapeutic targets.

More Related Videos

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.6K
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

10.6K

Related Experiment Videos

Last Updated: Mar 2, 2026

Visualization and Quantification of TGF&#946;/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

3.9K
Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.6K
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

10.6K

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGF-β) is a cytokine with diverse roles in tissue remodeling.
  • TGF-β signaling effects are context-dependent, often exhibiting distinct or opposing roles in disease progression.
  • The precise mechanisms behind TGF-β's cell- and process-specific actions remain unclear.

Purpose of the Study:

  • To elucidate a novel pathway mediating TGF-β1-induced angiogenesis.
  • To investigate the role of thrombospondin-4 (TSP-4) in TGF-β1 signaling and endothelial cell (EC) function.
  • To determine TSP-4's contribution to TGF-β1-driven tumor growth and angiogenesis in vivo.

Main Methods:

  • Investigated TSP-4 expression in endothelial cells (EC) following TGF-β1 stimulation.
  • Utilized SMAD3 activation assays to understand TSP-4 upregulation mechanisms.
  • Employed Thbs4 knockout mice and TSP-4 shRNA in EC cultures and in vivo models.
  • Administered TGF-β1 and SB-431542 (TGF-β1 inhibitor) in tumor models.

Main Results:

  • TGF-β1 upregulates thrombospondin-4 (TSP-4) in ECs, mediated by SMAD3 activation.
  • TSP-4 mediates pro-angiogenic effects of TGF-β1 in cultured ECs and in vivo.
  • Thbs4 knockout mice showed no increase in tumor mass or angiogenesis markers upon TGF-β1 injection.
  • TGF-β1 inhibition reduced tumor weight and cancer angiogenesis.

Conclusions:

  • TSP-4 is a key mediator of TGF-β1-induced angiogenesis.
  • The identified TSP-4 pathway contributes to TGF-β1's role in stimulating tumor growth.
  • Targeting TSP-4 may offer a strategy to inhibit TGF-β1-driven tumor angiogenesis.